1. Moore KH. “In the 1970s”. Women in the Medical Society. Ann Jervie Sefton, Nicholas Cheng, Ian G. Thong. eds. The Centenary Book of the Sydney University Medical Society. 1992; 190-193
  2. Moore KH. “Prolapse and Urinary Incontinence” Leader L, Bennett MJ, Wong F. eds. in Handbook of Obstetrics and Gynaecology, 4th Ed., 1996; 391-409
  3. Versi E, Defever M, Hu TW, Kobelt G, Moore KH, Subak L, Zinner N. “Socio-economic Considerations in Urinary Incontinence”. Report of World Health Organisation, Editors: Abrams P, Khoury S, Wein A. 1998; 22: 869-929 Health Publications Ltd., Plymouth
  4. Moore KH. “Conservative Therapy for Incontinence”. Invited Chapter, Monograph on Urinary Incontinence, Clinical Obstetrics and Gynaecology series. 2000; 14: 251-289 Balliere’s Clinical Obstetrics and Gynaecology
  5. Hu TW, Moore KH, Subak L, Versi E, Wagner T, Zinner N. “The economics of incontinence”. Report of World Health Organisation, Editors: Abrams P, Cardozo L, Koury S, Wein A. 2001; 14: 965-983 Health Publications Ltd., Plymouth
  6. Hu TW, Wagner TH, Hawthorne G, Moore KH, Subak L. “Economics of Incontinence”. Report of World Health Organisation, Editors: Abrams P, Cardozo L, Koury S, Wein A. 2005; 2: 75-95 Health Publications Ltd., Plymouth
  7. A Morris, Moore KH. “Extracorporeal magnetic stimulation”. In textbook of Pelvic Floor Rehabilitation. Editors: Schussler B, Moore KH, Baessler K, Norton P, Stanton SL. 2008; 196-200 Springer-Verlag London Limited
  8. J Hay Smith, Moore KH. “Evidence for the Effectiveness of Pelvic Floor Muscle Training in the Treatment and Antenatal Prevention of Female Urinary Incontinence”: In textbook of Pelvic Floor Rehabilitation.. Editors: Schussler B, Moore KH, Baessler K, Norton P, Stanton SL. 2008; 228-234  Springer-Verlag London Limited
  9. P Chiarelli, Moore KH. “Exercise Feedback, and Biofeedback”. In textbook of Pelvic Floor Rehabilitation. Editors: Schussler B, Moore KH, Baessler K, Norton P, Stanton SL. 2008 184-189 Springer-Verlag London Limited
  10. Moore KH, E Karantanis. “Outcomes measures in pelvic floor rehabilitation”. In textbook of Pelvic Floor Rehabilitation. Editors: Schussler B, Moore KH, Baessler K, Norton P, Stanton SL. 2008; 162-174 Springer-Verlag London Limited
  11. Moore KH, Hu TW, Subak L, Wagner TH, Duetekom, M. “Economics of Urinary & Faecal Incontinence, and Prolapse”. Report of World Health Organisation, Editors: Abrams P, Cardozo L, Koury S, Wein A. 2009; 1687-1712 Health Publications Ltd., Plymouth
  12. Moore KH, Subak L, Wagner TH, De Wachter S, Dudding T. “Economics of Urinary & Faecal Incontinence, and Prolapse”. Report of World Health Organisation, Editors:  Abrahams P, Cardozo L, Koury S, Wein A. 2012; 1829-1861 Health Publications Ltd., Plymouth.
  13. Moore KH, te West NID. “Bacterial Cystitis in Urogynaecology: an update”. Textbook of Female Urology and Urogynaecology; 4th Edition Eds: Cardozo L, Staskin D In Press 2015
  14. Moore KH, “Economic Aspects of Urinary Incontinence”. Textbook of Female Urology and Urogynecology, Fourth Edition , Eds: Cardozo L, Staskin D. 2015; Inform Health Care, London
  15. Wagner TH, Moore KH, Subak L, De Wachter S, Dudding T. “Economics of Urinary & Faecal Incontinence, and Prolapse”. Report of World Health Organisation, Editors:  Abrahams P, Cardozo L, Koury S, Wein A. 2016; Health Publications Ltd., Plymouth.

Peer Reviewed Publications

  1. Moore KH, Hay D, Imrie A, Watson A, Goldstein M. Oxybutynin Hydrochloride 3 mg in the treatment of women with idiopathic detrusor instability.  Brit J Urol 1990; 66: 479-485
  2. Moore KH, Sutherst JR. Response to treatment of detrusor instability in relation to psychoneurotic status. Brit J Urol 1990; 66: 486-490
  3. Moore KH, Richmond DH, Sutherst JR. Urinary acidity in relation to detrusor instability. Neurourol & Urodyn 1990; 9: 331-332
  4. Moore KH, Sill PR. Domiciliary fetal monitoring in a district maternity unit. Aust NZ J Obstets & Gynaecol 1990; 30: 36-40
  5. Skehan M, Moore KH, Richmond DH. The auditory stimulus of running water; its effect on urethral pressure.  Neurourol & Urodyn 1990; 9: 351-353
  6. Moore KH, Richmond DH, Sutherst JR, Imrie AI, Hutton JL. Crouching over the toilet seat:  Prevalence among British gynaecological outpatients and its effect upon micturition.  Brit J Obstets & Gynaecol 1991; 98: 569-572
  7. Moore KH, Richmond DH, Parys BT. Sex distribution of adult idiopathic detrusor instability in relation to childhood bedwetting. Brit J Urol 1991; 68: 479-482
  8. Moore KH, Vaillant C, Nameth J, Richmond D, Sutherst J. Vasoactive intestinal polypeptide in refractory detrusor instability.  Neurourol & Urodyn 1991; 10: 330-331
  9. Moore KH, Nickson P, Richmond DH, Sutherst JR, Manasse PR, & Helliwell TR. Detrusor mast cells in refractory idiopathic instability. Brit J Urol 1992; 70: 17-21
  10. Moore KH, Gilpin SA, Dixon JS, Richmond DH & Sutherst JR. Increase of presumptive sensory nerves of the urinary bladder in idiopathic detrusor instability. Brit J Urol 1992; 70: 370-372
  11. Moore KH, Richmond DH, Sutherst JR, Manasse P. Is severe “wetness” associated with severe “madness” in detrusor instability? Neurourol & Urodyn 1992; 11: 460-461
  12. Zeng XP, Moore KH, Burcher E. Characterization of Tachykinin NK-2 receptors in human urinary bladder. J Urol 1995; 153: 1688-1692
  13. Burcher E, Zeng XP, Farnsworth RH, Moore KH. Functional characterization of tachykinin NK-2 receptors in child urinary bladder.  Neurourol & Urodyn 1995; 14: 546-548
  14. Moore KH. Detrusor Instability in Women. Its significance for continence therapists. Invited Review, Brit J Physiotherapy 1996; 82: 52-57
  15. Bower WF, Moore KH, Shepherd RB, Adams R. The epidemiology of childhood enuresis in Australia. Brit J Urol 1996; 78: 602-606
  16. Millard RJ, Moore KH. Urinary incontinence: the cinderella subject. Invited Editorial.  Med J Aust 1996; 165: 124-125
  17. Bower WF, Moore KH. Frequency volume chart data from 322 incontinent children. Brit J Urol 1997; 80: 658-662
  18. Smet P, Moore KH, Jonavicius J. Distribution and colocalisation of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 1997; 77: 37-49
  19. Moore KH, Foote AJ, Siva S, King J, Burton G. The use of the bladder neck support prosthesis in combined genuine stress incontinence and detrusor instability.   ANZJOG 1997; 37: 440-445
  20. Bower WF, Moore KH, Adams RD, Shepherd RB. A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol 1998; 106: 2133-2136
  21. Moore KH, Foote AJ, Burton G, King J. An open study of the bladder neck support prosthesis in genuine stress incontinence.  Brit J Obstets & Gynaecol 1999; 106: 42-49
  22. Dowell CJ, Bryant CM, Moore KH, Simons AM. Calculation of the direct costs of urinary incontinence: the DBICI, a new test instrument.  Brit J Urol 1999; 83: 596-606
  23. Moore KH. Current controversies in the diagnosis, aetiology and management of detrusor instability. Critical Reviews in Physical and Rehabilitation Medicine. (Invited Review) 1999; 11: 35-61
  24. Millard R, Tuttle J, Moore KH, Susset J, Clarke B, Dwyer P, Davis BE. Clinical efficacy and safety of Tolterodine compared to placebo in detrusor overactivity. J Urol 1999; 161: 1551-1555
  25. Simons A, Cragg S, Moore KH. The sub-optimal accuracy of the bladderscan: reliability against a known volume, using a measure of agreement. Neurourol & Urodyn 1999; 18: 307-308
  26. Moore KH, Simons A, Dowell C, Bryant C, Prashar S.  Efficacy and user acceptibility of the urethral occlusive device in women with urinary incontinence. J Urol 1999; 162: 464-468
  27. Burcher E, Strigas J, Zeng XP, Shang F, Millard RJ, Moore KH. Autoradiographic localization of tackykinin and calcitonin gene-related peptide receptors in adult urinary bladder. J Urol 1999; 162: 464-468
  28. Werkstrom V, Lam DSH, Farnsworth RH, Awar N, Burcher E, Moore KH. In vitro contractile responses of detrusor to carbachol and neurokinin A, in children with recurrent urinary tract infection or day wetting.  Brit J Urol 2000; 85: 319-325
  29. Prashar S, Simons A, Bryant C, Dowell C, Moore KH. Attitudes to vaginal/urethral touching and device placement in women with urinary incontinence. Int Urogynaecol J 2000; 11: 4-8
  30. Moore KH, Simons A, Mukerjee C, Lynch W. Relative incidence of detrusor instability and bacterial cystitis found on the urodynamic test day. Brit J Urol 2000; 85: 786-792
  31. Lam DSH, Dias LS, Moore KH, Burcher E. Angiotensin II in child urinary bladder: functional and autoradiographic studies. Brit J Urol 2000; 86: 494-501
  32. Simons AM, Dowell CJ, Bryant CM, Prashar S, Moore KH. outcome Use of the Dowell Bryant incontinence cost index as a post-treatment measure. Neurourol & Urodyn. 2001; 20: 85-93
  33. Simons AM, Yoong WC, Buckland S, Moore KH. Inadequate repeatability of the one hour pad test: the need for a new incontinence outcome measure. Brit J Obstets & Gynae 2001; 108: 315-319
  34. Moore KH. The costs of urinary incontinence: human suffering and financial drain. Med J Aust 2001; 174: 436-437 (Invited Review)
  35. Moore KH, Ray F, Barden JA. Loss of purinergic P2X3 and P2X5 receptor innervation in human detrusor from adults with urge incontinence. J Neuroscience 2001; 21: RC166:1-6
  36. Bower WF, Moore KH, Adams RD. A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol 2001; 166: 2420-2422
  37. Clausen JA, Lynch WJ, Aslan P, Moore KH. Alterations in the distribution of GAP-43/P75NTR in urinary bladder from human urge syndrome/OAB. Neurourol & Urodyn 2001; 20: 399-401
  38. Bower WF, Moore KH, Adams RD. A novel clinical evaluation of childhood incontinence and urinary urgency. J Urol 2001; 166: 2411-2415
  39. Moore KH, Lam DSH, Lynch W, Burcher E. Role of tachykinin NK-2 receptors in non-cholinergic contractility of normal and unstable human urinary bladder. Peptides. 2002; 23: 1155-1160
  40. Moore KH, Louey M, Ip V, Swinfield J, Ho MP. The cost of a continence service in the acute hospital – is it being “counted”? Neurourol & Urodyn 2002; 21: 345-347
  41. Dietz HP, Moore KH, Steensma AB. Antenatal pelvic organ mobility is associated with delivery mode.  ANZJOG 2003; 43: 70-74
  42. Herbison P, Hay-Smith J, Ellis G, Moore KH. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Brit Med J 2003; 326: 841-847. Also published as BMJ USA 3 (June 2003) 319-22
  43. Qi JC, Li L, Li Yong, Moore KH, Madigan MC, Katsoulotos G, Krilis SA. An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc&RI+, Tryptase, and Chymase in a variety of human tissues. Journal of Histochemistry & Cytochemistry 2003; 51: 643-653
  44. Green P, Smoker I, Ho MT, Moore KH. Urinary incontinence in sub-acute care – a retrospective data analysis. Med. J Aust 2003; 178: 550-553
  45. Karantanis E, O’Sullivan R, Moore KH. The 24-hour pad test in continent women and men: normal values and cyclical alterations. Brit J Obstet & Gynae 2003; 110: 567-571
  46. Blackwell AL, Moore KH. Does detrusor overactivity ever cease? Repeat urodynamic testing at 1 to 9 years. Neurourol & Urodyn 2003; 22: 462-463
  47. Moore KH, O’Sullivan RJ, Simons A, Prashar S, Anderson P, Louey M. Randomized controlled trial of nurse continence advisor therapy versus standard urogynaecology regime for conservative incontinence treatment: Efficacy, costs and two year follow up. Brit.J Obstet & Gynae 2003; 110: 649-657
  48. Mansfield KJ, Mitchelson FJ, Moore KH, Burcher E. Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes. Eur J Pharmacol 2003; 482: 101-109
  49. Ray FR, Moore KH, Hansen MA, Barden JA. Loss of purinergic P2X receptor innervation in human detrusor and subepithelium from adults with sensory urgency. Cell and Tissue Res 2003; 314: 351-359
  50. O’Sullivan R, Simons A, Prashar S, Anderson P, Louey A, Moore KH. Is objective cure of mild undifferentiated incontinence more readily achieved than that of moderate incontinence? Costs and two year outcome. Int J Urogynaecol. 2003; 14: 193-198
  51. Morris A, Moore KH. The Contiform incontinence device – efficacy and patient acceptability. Int. J Urogynaecol 2003; 14: 412-417
  52. Millard RJ, Moore KH, Rencken, Yalcin I, Bump RC. Duloxetine vs placebo in treatment of stress urinary incontinence: a four continent randomized clinical trial. Brit J Urol 2004; 93: 311-318
  53. Blackwell AL, Yoong W, Moore KH. Criterion validity, test retest reliability and sensitivity to change of the St George Urinary Incontinence Score. Brit J Urol 2004; 93: 331-335
  54. Karantanis E, Fynes M, Moore KH, Stanton SL. Comparison of the ICIQ-SF and 24-hour pad test with other measures for evaluating the severity of urodynamic stress incontinence. Int.Urogynecol J 2004; 15: 111-116
  55. Deans CL, Morris AR, O’Sullivan R, Moore KH. Voiding difficulty and other adverse events after tension free vaginal tape. Aust NZ Cont J. 2004; 10: 34-41
  56. Morris AR, Mullan G, Roscioli T, Buckley MF, Moore KH. A genetic linkage study of detrusor overactivity. Neurourol & Urodyn 2004; 23: 404-406
  57. O’Sullivan R, Karantanis E, Stevermuer TL, Allen W, Moore KH. Definition of mild, moderate and severe incontinence on the 24-hour pad test. Brit J Obstet & Gynae 2004; 111: 859-862.
  58. Moore KH. Duloxetine: a new approach for treating stress urinary incontinence. Int J Gynecol Obstet 86 Suppl 1 2004, S53-S62 (Invited Review)
  59. Moore KH. Pelvic Floor Dysfunction: how best to treat? (Invited Review) RANZCOG Obs & Gynae. 2004; 6: 195-196
  60. Morris A, Ho MT, Walsh J, Gonski G, Lapsley H, Moore KH. Costs of managing urinary and faecal incontinence in a subacute care facility. A “bottom up” approach. Neurourol & Urodyn 2005; 24: 56-62
  61. Karantanis E, Allen W, Stevermuer TL, Simons AM, O’Sullivan R, Moore KH. The repeatability of the 24-hour pad test. Int Urogynecol J 2005; 16: 63-68
  62. Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Brit J Pharmacol 2005; 144: 1089-1099
  63. Schofield EC, Clausen JA, Burcher E, Moore KH. GAP-43 immunoreactivity in subepithelial and detrusor muscle nerve fibres in females with refractory idiopathic detrusor overactivity. Neurourol & Urodyn. 2005; 24: 325-333
  64. Kuteesa W, Moore KH. Anticholinergic drugs for overactive bladder. (Invited review) Australian Prescriber 2006; 29: 22-24
  65. Sadananda P, Lazzaro VA, Moore KH, Burcher E, Mansfield KJ. Urothelial cells isolated from urine of female subjects release ATP in response to acid. Neurourol & Urodyn. 2006; 25: 559-560
  66. Karantanis E, Wang K, Fynes M, Moore KH. 24-hour pad test: a comparison of normal ranges between two countries and according to the type of pad used. Neurourol & Urodyn. 2006; 25: 608-609
  67. Woodman, JR. Moore KH, Thornton M, Burns H, King D. Anal incontinence after transanal versus transvaginal repair of rectocoele: matched pair cohort analysis. Aust NZ Cont J 2007; 13: 40-45
  68. Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity. BJU Int. 2007; 99: 1433-1438
  69. Chua WC, Liu L, Mansfield KJ, Vaux KJ, Moore KH, Millard RJ, Burcher E. Age-related changes of P2X1 receptor mrna in the bladder detrusor from men with and without bladder outlet obstruction. Experimental Gerontology 2007; 42: 686-692
  70. Foote AJ, Moore KH. The cost of urogynaecological treatments: which are more cost effective. ANZJOG 2007; 47: 240-246
  71. Morris A, O’Sullivan R, Dunkley P, Moore KH. Extra corporeal magnetic stimulation in female detrusor overactivity; simultaneous cystometry testing and a randomized sham controlled trial. European Urology 2007, 52: 876-883
  72. Steers WD, Herschorn S, Kreder KJ, Moore KH, Strohbehn K, Yalcin I, Bump RC for the Duloxetine OAB Study Group. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. Brit J Urol Int 2007; 100: 337-345
  73. Moore KH, Sarma S. The changing face of detrusor overactivity therapy in Australia (invited review). Aust & NZ Cont J, 2007; 13: 90-94
  74. Morris AR, Westbrook JI, Moore KH. A longitudinal study over 5 to 10 years of clinical outcomes in women with idiopathic detrusor instability. Brit J Obs & Gynae 2007; 115: 239-246
  75. Allen WA, Leek H, Izurieta A, Moore KH. Update: the “Contiform” intravaginal device in four sizes for treatment of stress incontinence. Int J Urogynaecol. 2008; 19: 757-761
  76. Sarma S, Thakkar K, Hayes W, Karantanis E, Hawthorn G, Moore KH. The Development of an Incontinence Treatment Motivation Questionnaire for patients undergoing Pelvic Floor Physiotherapy in the treatment of Stress Incontinence.  J Urogynaecol. 2009; 20: 1085-1093
  77. Sarma S, Ying, T, Moore KH. Long term vaginal ring pessary use:  discontinuation rates and adverse events.  Brit J Obstet & Gynae 2009; 116: 1715 -21
  78. Moore KH. Is the current ‘definition’ of bacterial cystitis appropriate for women with coexistent lower urinary tract symptoms (LUTS)?  ANZ Continence J. 2009; 15: 4: 124-125
  79. Sarma S, Hersch M, Siva S, Dietz H, Moore KH. Women who cannot contract their pelvic floor muscles – avulsion or denervation?  Neurology & Urodyn, 2009; 28: 680-681
  80. Walsh CA, Moore KH, Recurrent stress urinary incontinence after synthetic midurethral sling procedure.  Obstet & Gynae 2010; 115: 1296- 301
  81. Walsh CA, Allen W, Moore KH. ‘Urinary incontinence’ post-radiotherapy:  A diagnostic conundrum.  Obstet & Gynae, 2010; 30: 424-5
  82. Nitti VW, Kopp Z, Lin ATL, Moore KH, Oefelein M, Mills W. ‘Can we predict which patient will fail drug treatment for overactive bladder?  A think tank discussion.’ Neurourol. Urodyn, 2010; 29: 652-657
  83. Birder LA, Kanai AJ, Cruz F, Moore KH, Fry CH. ‘Is the Urothelium Intelligent?’  Urodyn. 2010; 29: 598-602
  84. Cheng Y, Mansfield KJ, Allen W, Walsh CA, Burcher E, Moore KH, Does ATP release into cystometric bladder washings contribute to the signalling of urgency in women with bladder dysfunction? J Urol 2010, 183; 3:1082-6
  85. Woodman JR, Mansfield KJ, Lazzaro VA, Lynch W, Burcher E, Moore KH, Immunocytochemical characterisation of cultures of human bladder mucosal cells. BMC Urology, 2011; 11: 5-30
  86. Walsh CA, Moore KH. Overactive bladder in women: does low-count bacteriuria matter?  An Invited review.  Neuro & Urodyn.  2011; 30: 32-37
  87. Cheng Y, Mansfield KJ, Sandow SL, Sadananda P, Burcher E, Moore KH, Porcine bladder and urothelial, myofibroblast and detrusor muscle cells: characterisation and ATP release. Frontiers in Pharmacology 2011; 2: 27-36
  88. Indraratna P, Walsh CA, Moore KH. Intra-operative cystoscopy in gynaecological surgery.  Aust ANZJOG 2011; 51: 272-5
  89. Cheng Y, Walsh CA, Mansfield KJ, Allen W, Moore KH. Relationship between bacteriuria and ATP concentrations in voided urodynamics fluid: 2-year prospective study. Neurourol & Urodyn 2011; 30: 921-922
  90. Walsh CA, Allen W, Parkin K, Mukerjee C, Moore KH. “Low-count” bacteriuria in refractory idiopathic detrusor overactivity versus controls. Urogynaecologia 2011; 25: e4 11-15
  91. Walsh CA, Siddins A, Parkin K, Mukerjee C, Moore KH. Prevalence of “low count’ bacteriuria in female urinary incontinence versus continent female controls: a cross-sectional study. Int. Urogynaecol J, 2011; 22: 267-272
  92. Shahab RB, Sarma S, Moore KH, Kuteesa WMA, Cebola M, Walsh CA, Wang YA, Karantanis E. Randomized Controlled Trial of Cough Test versus no Cough Test in the Tension-Free Vaginal Tape Procedure effect upon Voiding Dysfunction and 12 month Efficacy. Int Urogynecol J, 2012; 23: 435-441.
  93. Karantanis E, Painter V, Moore KH. Does patient activity level affect 24-hour pad test results in stress-incontinent women? Neurol & Urodyn 2012; 31: 143-147
  94. Ho M, Kuteesa W, Short A, Eastwood A, Moore KH. Incontinence after childbirth: Long-term analysis of direct costs of conservative and surgical therapy. Aust NZ Cont J 2012; 18: 10-19
  95. Hannan TJ, Totsiks M,  Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. Host-Pathogen Checkpoints and Population Bottlenecks in Persistent and Intracellular Uropathogenic E Coli Urinary Tract Infection. FEMS Microbiol Rev. 2012 36: 616-48
  96. Walsh CA, Cheng Y, Mansfield KJ, Parkin K, Mukerjee C, Moore KH. Decreased intravesical ATP in patients with refractory detrusor overactivity and bacteriuria.  J Urol 2013; 189: 1383-7.
  97. Cheng Y, Mansfield KJ, Allen W, Millard RJ, Burcher E, Moore KH. Correlation between Cystometric volumes, ATP release, and pH in women with overactive bladder versus controls. Neurourol Urodyn. 2013; 32: 969-73
  98. Davidson JE, Moore KH. Is Pelvic Floor Muscle Training as Effective for Urinary Incontinence in the Elderly as Compared to the General Population? A&NZ Cont J 2013: 19: 18-25
  99. Mansfield KJ, Cowan T, Cheng Y, Allen W, Moore KH. Predicting refractory Detrusor overactivity: Are there any clues at Diagnosis? EMJ Urology 2013; 1: 87-91
  100. Moore KH, Allen W, Woodman J, Bushati A, Burcher E. Response to resiniferatoxin in women with refractory detrusor overactivity: Role of bacterial cystitis. Aust NZ Cont J 2013; 19: 66-73.
  101. Deepak I, Sundac L, Benjamin W, Moore KH, Ulett G. Asymptomatic bacteriuria: prevalence rates of casual microbes, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiol Lett. 2013; 346: 1-10
  102. Wong V, Moore KH. Female urinary incontinence. Medical Observer 2013; 25-27
  103. Wong V, Kim S, Moore KH. Why are some women with pelvic floor dysfunction unable to contract their pelvic floor muscles? ANZJOG 2013; 54: 198-205 Oct 1. doi: 10.1111/ajo.12133
  104. Chen Z; Wong V, Wang A, Moore KH. Nine year objective and subjective follow up of the Ultra-Lateral anterior repair for cystocele. Urogyn J, 2013; 25: (3) 387-392
  105. Bahadory F, Moore KH; Liu Lu; Burcher E. Gene expression and functional role of muscarinic, tachykinin and purinergic receptor. Frontiers in Pharmacology 2013; 4: 1-7
  106. Hagen S, Stark D, Glazener C, Dickson S, Barry S, Elders A, Frawley H, Galea MP, Logan J, McDonald A, McPherson G, Moore KH, Norrie J, Walker A, Wilson D, Individualised Pelvic Floor muscle training in women with pelvic organ prolapse: a multicentre randomised controlled trial. Lancet 2014; 383: 796-806
  107. Lim V, Khoo J, Wong V, Moore KH. Recent studies of genetic dysfunction in pelvic organ prolapse: the role of collagen defects. Aust NZ J Obstets & Gynaecol 2014; 54: 198–205
  108. Moore KH, Malykhina AP. What is the role of Covert Infection in Detrusor Overactivity, and other LUTD? ICI-RS Neurol & Urod 2014; 33: 606-610
  109. Karantanis E, Stanton S, Parsons M, Robinson D, Blackwell AL, Cardozo, Moore KH. Women’s preferences for treatment for stress incontinence – physiotherapy or surgery. Aust & NZ Continence Journal 2014; 20: 34-40
  110. Cheng Y, Mansfield KJ, Allen W, Chess Williams R, Moore KH. ATP During Early Bladder Stretch is important for Urgency in Detrusor Overactivity Patients. BioMed Research Int J 2014:
  111. Bishop G, Moore KH. Painful bladder syndrome. Medicine Today; 2014; 15: 401-406
  112. te West NID, Moore KH. Recent Developments in the non-surgical Management of Pelvic Organ Prolapse. Invited Review 2014: Curr Obstet Gynecol Report 3: 172-179
  113. Cheng Y, Moore KH. Study of Oestrodiol Effect Upon ATP release in Primary Pig Urothelium Cell Culture: A Possible Mechanism of Action for Topical Vaginal Oestradiol? Neurology and Urodynamics 2014; 33: 809-810.
  114. Bahadory F, Mansfield KJ, Moore KH, Burcher E, Liu L. Gene Expression of Onabotulinum Toxin A Target Proteins in Porcine Bladder: Possible effect on substance P Release? Neurourol & Urodyn 2014; 33: 719-720.
  115. te West NID, Moore KH. Urinary Tract Infection in Gynaecology and Obstetrics. Obstetrics, Gynaecology & Reproductive Medicine, 2014; 24: 321-325.
  116. te West NID, Parkins K, Hayes W, Costa D, Kasparian N, Moore KH. Does motivation predict outcome of Pelvic Floor Muscle retraining?  Neurourol & Urodyn 2015 DOI: 10.1012/nau22917
  117. McKenna JB, Parkin K, Cheng Y, Moore, KM. Objective Efficacy of the TVT in Obese versus Non-Obese Women at Median 5 year Follow up. Aust NZ Cont J 2016;  22: 25-30.
  118. Wong V, Rodirgo Guznian R, Sheu KL, Chow D, Moore KH, Dietz P. Laparoscopic Sacrocolpopexy: How low does the mesh go? USObsGyn 2016; doi.10.1002/uog.15882
  119. Oryszczyn J, Lim V, te West NID, Jeffery S, Souget J, Weber M, Roovers JP, Moore KH. The Effect of Vaginal Oestriol on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot study. Gyn & Obstet Invest. Gynecol Obstet Invest DOI: 10.1159/000445074
  120. A Budden , te West NID, Sturgess A, Moore KH. Pelvic Floor Dysfunction in Female Sjogren’s Syndrome: An 8 Year Audit Int Urogyn J 2016 doi 10.1007/500192-01629859
  121. Cheng Y, Chen Z, Gawthorne JA, Mukerjee C, Varettas K, Mansfield KJ, Schembri MA, Moore KH Detection of intracellular bacteria in exfoliated urothelial cells from women with urge incontinence Pathogens and Disease Aug 2016 doi 10.1093 femspdftw067
  122. Woodman J, Cowan T, Karantanis E, Moore KH. A Longitudinal study of asymptomatic rectocoele. Aust NZ Cont J. 2016; 22: 26-30.
  123. Hafiz Sana-Ur-Rehman, Markus I, Moore KH. Mansfield KJ, and Lu Liu “Expression and localization of pannexin-1 and CALHM1 in porcine bladder and their involvement in modulating ATP release” American Journal of Physiology – Regulatory, Integrative and Comparative Physiology Accepted 2017.
  124. Bates LJ, te West NID, Lynch W, Moore KH. Detrusur overactivity and atherosclerosis, are they linked? Atherosclerosis screening using Ankle Brachial Index and Pulse Wave Velocity in women with detrusor overactivity A&NZ Cont J 2017: 22: 95-96
  125. Daneel L, te West NID, Moore KH. Does monthly self-removal of vaginal ring pessaries for stress urinary incontinence/prolapse resuce complication rates? A 5 year audit* A&NZ Cont J 2017: 22: 105-106

recent Published Abstracts

  1. Cheng Y, Chen Z, Allen W, Mukerjee C, Varettas K, Mansfield KJ, Schembri MA, Moore KH. Bacterial Filaments are more common in Detrusor Overactivity than controls:  Evidence for Intracellular Bacterial invasion of Urothelial Cells. Int. Urogyn J, 2014; 25: s90-91, IUGA Washington.
  2. Cheng Y, Moore KH. Study of oestradiol effect upon ATP release in primary pig urothelial cell culture: a possible mechanism of action for topical vaginal oestradiol?  2014, ICS October Rio De Janerio –  Neurourology & Urodynamics 2014; 33: 809-810
  3. McKenna J, Parkin K, Cheng Y, Moore KH. The Objective Efficacy of the TVT in Obese versus Non-Obese Women at Median 5 year Follow up. AGES Meeting Adelaide – Prize for best lecture
  4. Campbell N L, Cheng Y, Lochhead A, Mansfield KJ, Moore KH. Can we distinguish between cell types present in MSU and catheter urine samples from women with incontinence? ICS Rio – Poster
  5. Oryszczyn J, Lim V, te West NID, Jeffery S, Souget J, Weber M, Roovers J P, Moore KH. The effect of vaginal oestrogen on subjective and objective symptoms of SUI and vaginal atrophy: an international multi-centre observational pilot study ICS Rio – Neurology and Urodynamics 2014; 33: 719-720.
  6. Bahadory F, Mansfield KJ, Moore KH, Burcher E, Liu L. Gene Expression of Onabotulinum Toxin A Target Proteins In Porcine Bladder: Possible Effect on Substance P Release? ICS Rio – Neurourology & Urodynamics 2014; 33: 719-720